A comparison of the effect of five phenothiazines on hepatic CYP isoenzymes in rats

Pharmacology and Toxicology

Volumn 85, Issue 5, 1999, Pages 252-256

  Tateishi, Tomonori ^a   Kumai, Toshio ^a   Watanabe, Minoru ^a   Tanaka, Masami ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CYTOCHROME P450 ISOENZYME; LIVER ENZYME; PERPHENAZINE; PHENOTHIAZINE; PHENOTHIAZINE DERIVATIVE; THIORIDAZINE; TRIFLUOPERAZINE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INDUCTION; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0032712478     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb02018.x     Document Type: Article

References (19)

1. Cribb, A., E., S. P. Spielberg & G. P. Griffin: N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab. Disp. 1995, 23, 406-414.
2. Davis, J. M.: Dose epuivalence of the antipsychotic drugs. J. Psychiat. Res. 1974, 11, 65-69.
3. Engel, G., U. Hofmann, H. Heidemann, J. Cosme & M. Eichelbaum: Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin. Pharmacol. Therap. 1996, 59, 613-623.
4. Guengerich, F. P.: Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Canser Res. 1988, 48, 2946-2954.
5. Harman, A. W., D. B. Prewin & B. G. Priestly: Comparative enzyme-inducting effects of chlorpromazine and fluphenazine therapies in psychotic patients. Chlorpromazine treatment shortens antipyrine half-lift. Psychopharmacology 1980, 69, 35-37.
6. Ioannides, C. & D. V. Parke: The cytochrome P448A unique family of enzymes involved in chemical toxicity and carcinogenesis. Biochem. Pharmacol. 1987, 36, 4197-4207.
7. Kawajiri, K. & S.-I. Hayashi: The CYPI family. In: Cytochrome P450: Metabolic and toxicological aspects. Ed.: C. Ioannides. Boca Raton, CRC Press Inc., 1996. pp. 77-98.
8. Lassen J. B.: Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone. Acta Pharmacol. et toxicol. 1977, 40, 418-429.
9. Lowry, O. H., N. J. Rosebrough, A. L. Farr & R. J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
10. Murray, M.: Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine. Biochem. Pharmacol. 1992, 44, 1219-1222.
11. Niwa T., H. Kaneko, Y. Naritomi, A. Togawa, T. Shiraga, K. Iwasaki, Z. Tozuka & T. Hata: Species and sex differences of testosterone and nifedipine oxidation in liver microsomes of rat, dog and monkey. Zenobiotics 1995, 25, 1041-1049.
12. Omura, T. & R. Sato: The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 1964, 239, 2370-2378.
13. Paolini, M., R. Mesirca, L. Pozzetti, A. Sapone & G. Cantelli-Forti: Molecular non-genetic biomarkers related to fenarimol cocaricinogenesis: organ- and sex-specific CYP induction in rat. Cancer Lett. 1996, 101, 171-178.
14. Peter, P., R. Böcker, P. H. Beaune, M. Iwasaki, F. P. Guengerich & C. S. Yang: Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 1990, 3, 566-573.
15. Sharer, J. E. & S. A. Wrighton: Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metab. Disp. 1996, 24, 487-494.
16. Spina, E., C. Martines, A. P. Caputi, J. Cobaleda, B. Pinas, J. A. Carrillo & J. Benitez: Debrisoquine oxidation phenotype during neuroleptic monotherapy. Eur. J. Clin. Pharmacol. 1991, 41, 467-470.
17. Tateishi, T., M. Watanabe, H. Hakura, M. Tanaka, T. Kumai & S. Kobayashi: Liver damage induced by bile duct ligation affects CYP isoenzymes differently in rats. Pharmacology & Toxicology 1998, 82, 89-92.
18. von Bahr, C., E. Spina, C. Bergersson, O. Ericsson, M. Goransson, T. Henthorn & F. Sjöqvist: Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes. Biochem. Pharmacol. 1985, 35, 2501-2505.
19. Wattenberg, L. W. & J. L. Leong: Effects of phenothiazines on protective systems against polycyclic hydrocarbons. Cancer Res. 1965, 25, 365-370.